InhibrxのSMA 50
InhibrxのSMA 50は何ですか。
Inhibrx, Inc.のSMA 50は$13 +13.06%です。
SMA 50の定義は何ですか。
SMA 50は、過去50日間の終値の非加重平均として計算された過去50日間の平均株価である。
Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
NASDAQのセクタHealth CareにおけるSMA 50の企業と比べるInhibrx
Inhibrxは何をしますか。
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcinoma; INBRX-105, a tetravalent conditional agonist of programmed death-ligand 1 and a conditional agonist of 4-1BB that is in Phase 1 clinical trials to treat patients with locally advanced or metastatic solid tumors; and INBRX-101, an alpha-1 antitrypsin (AAT)-Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with AAT deficiency. It also provides INBRX-106, a hexavalent agonist of OX40 for a range of oncology indications. The company was founded in 2010 and is headquartered in La Jolla, California.
Inhibrxと類似のsma 50
- Altimeter GrowthのSMA 50は$13 -18.30%です。
- Northern Technologies InternationalのSMA 50は$13 -8.36%です。
- Ocean Bio-ChemのSMA 50は$13 +0.00%です。
- Gem DiamondsのSMA 50はGBX13 -9.98%です。
- CropEnergies AGのSMA 50は€13 +1.24%です。
- InterPrivate Acquisition CorpのSMA 50は$13 +0.00%です。
- InhibrxのSMA 50は$13 +13.06%です。
- Blackrock & Resources TrustのSMA 50は$13 -6.23%です。
- JD.comのSMA 50は$13 +0.88%です。
- Plexus plcのSMA 50はGBX13 -12.48%です。
- Corporate Travel ManagementのSMA 50はAUD$13 -12.07%です。
- Act II Global AcquisitionのSMA 50は$13 -3,795.52%です。
- MarcusのSMA 50は$13 +9.36%です。